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The recognition of viral components by host pattern-
recognition receptors triggers the induction of the
antiviral innate immune response. Toll-like receptor
9 (TLR9) and NLRP3 inflammasome were shown to
be the principal specific sensors of viral double-
stranded DNA. Here we present evidence that
macrophages in vivo activated an innate immune
response to a double-stranded DNA virus, adeno-
virus (Ad), independently of TLR9 or NLRP3 inflam-
masome. In response to Ad, macrophage-derived
IL-1a triggered IL-1RI-dependent production of
a defined set of proinflammatory cytokines and che-
mokines. The IL-1a-mediated response required
a selective interaction of virus arginine-glycine-as-
partic acid (RGD) motifs with macrophage b3 integ-
rins. Thus, these data identify IL-1a-IL-1RI as a key
pathway allowing for the activation of proinflamma-
tory responses to the virus, independently of its
genomic nucleic acid recognition.
INTRODUCTION
Induction of the antiviral innate immune response depends on
the recognition of viral components by host pattern-recognition
receptors (PRRs) (Janeway and Medzhitov, 2002). The natural
diversity of virus-associated nucleic acids makes them a legiti-
mate target for recognition by specific cellular sensors that acti-
vate antiviral defense. In recent years, considerable evidence
has been accumulated suggesting that intracellular sensors of
virus-associated nucleic acids play an important role in recog-
nizing virus pathogens and restricting their reproduction in host
cells. Endosomal recognition of the viral double-stranded (ds)
DNA by Toll-like receptor 9 (TLR9), dsRNA by TLR3, and110 Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc.single-stranded (ss) RNA by TLR7 and TLR8 was shown to be
critical for type I interferon production by plasmocytoid DCs
(pDCs) in response to their infection with various virus pathogens
(see review in Takeuchi and Akira, 2009).
When virus particles enter the cytoplasm, TLR-independent
mechanisms become engaged to ensure pathogen detection
and alert the host of ongoing infection. The cytosolic RNA heli-
cases MDA-5 and RIG-I can recognize dsRNA and trigger type I
interferon production (Moore and Ting, 2008; Takeuchi andAkira,
2009). RIG-I also recognizes 50-triphosphate of a ssRNA, the
molecular structure associated with viral infection (Hornung
et al., 2006; Pichlmair et al., 2006). Recent studies also indicate
that a supramolecular complex of proteins, NLRP3 inflamma-
some, consisting of caspase-1 (encoded by Casp1), ASC (en-
codedbyPycard), andNLRP3 (encodedbyNlrp3),may recognize
viral and microbial dsDNA in the cytosole (Muruve et al., 2008).
The activation of NLRP3 inflammasome by dsDNA leads to the
proteolytic processing of pro-IL-1b, resulting in the release of
IL-1band thesubsequentactivationof acascadeofproinflamma-
tory cytokines and chemokines in an IL-1RI-dependent manner.
Taken together, these data suggest that an elaborate network
of sensors localized in the endosomes and cytoplasm triggers
the activation of antiviral innate immune and inflammatory
responses after the detection of virus-associated nucleic acids.
Adenovirus (Ad) is a nonenveloped virus with a linear dsDNA
genome. Intravenous injection of Ad induces rapid activation of
innate immune and inflammatory responses. Although these
responses can be severe and even fatal at high doses of the virus
(Brunetti-Pierri et al., 2004; Raper et al., 2003), the molecular
sensors of Ad and mediators of Ad-induced inflammation
in vivo remain poorly defined. Here we show that in response
to Ad, macrophages in vivo activate a cascade of proinflamma-
tory cytokines and chemokines independently of TLR9 and
NLRP3 inflammasome. Furthermore, we found that Ad triggers
an innate immune response via activation of IL-1a, and not IL-
1b or type I interferon. Ad interaction with cell surface receptors
and b3 integrins triggers IL-1a activation independently of
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PRR. Moreover, although IL-1a was earlier implicated in acti-
vating inflammation in response to cell damage or stress, our
data show the involvement of the IL-1a-IL-1RI pathway in the
induction of host antiviral responses.
RESULTS
Phagocytic Cells in Splenic Marginal Zone Accumulate
Ad In Vivo
Extensive previous studies have demonstrated that tissue
phagocytic cells play a critical role in mounting innate immune
response to blood-borne Ad in vivo. Although the role of resi-
dential macrophages, Kupffer cells, in trapping Ad particles in
the liver is well documented (Figure S1A available online; Lieber
et al., 1997; Worgall et al., 1997), the identity of the cells in other
tissues that trap blood-borne Ad, specifically in the spleen, is
poorly defined. We injected mice with human Ad serotype 5,
the most commonly used serotype in clinical trials, and
analyzed which specific cell types were interacting with the
Ad particles in the spleen. A gross evaluation of the Ad distribu-
tion in the spleen revealed that the vast majority of virus
particles were associated with cells in the marginal zone
(Figure 1A). Staining the spleen sections with Ad-specific anti-
body (Ab) and Abs for various cell type-specific markers re-
vealed that CD169- and MARCO-positive marginal zone
macrophages (MZMf), but not other cell types, including IgM-
positive marginal zone B cells, CD68-positive macrophages,
or cells expressing B220, Gr1, CD11b, or CD3 markers, were
colocalized with Ad particles after intravascular virus delivery
(Figures 1B and 1C; Movies S1–S3, Figure S2; and data not
shown). Although we cannot formally exclude that other cell
types in the spleen accumulate low amounts of Ad particles,
which are undetectable by these immunostaining approaches,
our data are consistent with recent findings implicating
CD169-positive macrophages in the sequestering of lymph-
borne viruses, including Ad, in the lymph nodes (Junt et al.,
2007).
Macrophages Activate IL-1RI-Signaling Pathway
in Response to Ad In Vivo
To better define mediators involved in the initiation of this
response, we injected C57Bl/6J mice with Ad5 and an Ad that
cannot bind its primary cell attachment receptor inmice because
of a mutation in its fiber capsid protein (Ad5/35L) (Shayakhmetov
et al., 2005b). At 30 min, 6 hr, and 24 hr, liver and spleen were
harvested and transcriptional activation of proinflammatory
cytokine and chemokine genes was analyzed by RNase protec-
tion assay. In agreement with earlier findings (Shayakhmetov
et al., 2005b), this analysis revealed that genes for IL-1a, IL-1b,
TNF-a, and CXCL2 (MIP-2), but not for type I interferon (IFN-
a4; Figure S1B) and IFN-b (data not shown), were transcription-
ally activated within 30 min of virus administration. An identical
pattern of gene induction was observed after Ad injection in
Balb/c, B6.129, and NOD-SCID mice (data not shown). This
analysis also showed that the amounts of mRNA for these proin-
flammatory genes in the spleen were significantly higher then
those in the liver (Figures S1B and S1C).Earlier reports suggested that TLR9, IFN-type I receptor, and
IL-1RI signaling might be involved in initiating anti-Ad innate
immune responses (Muruve et al., 2008; Nociari et al., 2007;
Shayakhmetov et al., 2005b; Zhu et al., 2007b). To define
whether the early expression of proinflammaroty cytokines
and chemokines depends on the signaling of these receptors,
we injected Ad in Il1r1/, Ifnar/, and Tlr9/ mice (Hemmi
et al., 2000; Kolumam et al., 2005). Analysis of the transcrip-
tional activation of IL-1a, IL-1b, CXCL1 (KC), CXCL2, and other
proinflammatory cytokines and chemokines (data not shown)
showed that the absence of the type I IFN or TLR9 receptors
did not change the amounts of mRNA for these cytokines and
chemokines in response to Ad administration (Figure 1D).
However, the activation of Cxcl1 and Cxcl2, but not Il1a or
Il1b, genes was dependent on IL-1R signaling (Figure 1D).
Because the transcriptional activation of proinflammatory cyto-
kine and chemokine genes was dramatic by 30 min after Ad
injection (Figure S1B), we analyzed earlier time points to deter-
mine the earliest time at which cells respond to a pathogen
entry. We found that transcriptional activation of Il1a, Il1b, and
Cxcl1 genes could be detected within 10 min after virus admin-
istration (Figure 1E). However, the full-scale activation of Cxcl1
and Cxcl2 genes required IL-1RI signaling. This IL-1RI-depen-
dent activation of Cxcl1 and Cxcl2 genes was observed as early
15 and 25 min after virus administration, respectively, and did
not occur in Il1r1/ mice (Figure 1F). The analysis of proinflam-
matory proteins in the spleen showed that Ad induced the
production of a specific set of cytokines and chemokines with
peak levels at 1 hr to 2 hr after Ad injection (Figure 1G;
Figure S3). Again, the production of the vast majority of acti-
vated proinflammatory mediators, including CXCL1, CXCL2,
CCL2 (MCP-1), IL-6, and CXCL10 (IP-10), but not IL-1a and
IL-1b, depended on functional IL-1RI signaling (Figure 1H;
Figure S3).
To analyze whether the macrophage response to Ad in vivo
was dose dependent, we administered Ad at varying doses
from 109 to 1011 virus particles per mouse. These doses of the
virus correspond to actual doses ranging from 10 to 1000 virus
particles per one marginal zone MARCO- or CD169-positive
cell (see Supplemental Experimental Procedures). This analysis
demonstrated that the transcriptional activation of IL-1a, IL-1b,
and CXCL1 could be detected even at the lowest dose of Ad
(Figures S4A and S4B). The dose-dependent activation of proin-
flammatory cytokines and chemokines was also observed at the
protein level (Figure S4C). A dose-dependent increase in virus
accumulation in macrophages was further confirmed by immu-
nofluorescent staining of virus particles on spleen sections
(Figure S4D).
Collectively, these data demonstrate that CD169- and
MARCO-positive MZMf trap blood-borne Ad and within 10
min initiate the activation of a specific set of proinflammatory
cytokines and chemokines. This activation occurs independently
of TLR9 or IFN-IR signaling; however, the majority of cytokines
and chemokines required functional IL-1RI for their activation.
MZMf-Derived IL-1a Is a Dominant Activator
of the Ad-Triggered Innate Immune Response
For IL-1RI, both IL-1a and IL-1b can act as functionally active
agonists (Dinarello, 1996). Because Ad activates theImmunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc. 111
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IL-1a Activates Innate Immunity to AdenovirusFigure 1. Splenic Marginal Zone Macrophages Trap Adenovirus and Initiate an IL-1RI-Dependent Innate Immune Response In Vivo
(A) Distribution of Ad particles in the spleen 30 min after virus injection. RP, red pulp; GC, germinal center; MZ, marginal zone. Ad antibody stain is red.
(B and C) Colocalization of Ad particles (red) with (B) CD169- or (C) MARCO-positive macrophages in the splenic MZ.
(D)mRNA expression for IL-1a, IL-1b, CXCL1, and CXCL2 in the spleen 30min after Ad injection. Graphs showmean ±SD, n = 4. *p < 0.01. Except for the columns
indicated by the star, no statistically significant differences between experimental groups andWT group were identified (p > 0.05). C,mock-infectedmice, treated
with saline; AU, arbitrary units.
(E and F) Kinetics of the transcriptional activation of Il1a, Il1b,Cxcl1, andCxcl2 in wild-type (E) or Il1r1/ (F) mice analyzed by the RNase protection assay. Repre-
sentative gels with mRNA for corresponding cytokines and chemokines are shown. Individual mice were injected with Ad and sacrificed at indicated time points.
(G) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and Il1r1/mice 1 hr after Ad
injection, determined by Proteome Profiler antibody array. Representative blot from four independent experiments is shown. As a positive control for inflamma-
tory cytokine and chemokine induction, mice were injected with LPS.
(H) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were
determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 3. Mock, negative control mice injected with saline; *p < 0.01.transcription and synthesis for both of these cytokines within
10 min of intravenous virus injection, we injected virus into
control C57Bl/6J mice or mice deficient in IL-1a (Horai et al.,
1998) or IL-1b (Shornick et al., 1996) and analyzed transcription
of Il1a, Il1b, and Cxcl1 and Cxcl2 (as markers of functional IL-1RI
signaling). These analyses revealed that the transcription of Il1a
and Il1b genes was activated independently of each other
(Figures 2A and 2B). Moreover, we found that the transcription
of Cxcl1 and Cxcl2 genes after Ad injection was identical in
Il1b/ and wild-type mice. In contrast, Cxcl1 and Cxcl2 gene112 Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc.activation was nearly abolished in Il1a/mice, and the amounts
of these chemokines in Il1a/ and Il1r1/mice were not statis-
tically different (Figures 2A–2D). Administration of Il1a/ mice
with lipopolysaccharide (LPS) induced the robust activation of
IL-1b, CXCL1, and CXCL2, demonstrating that the absence of
the IL-1a does not render these mice deficient at activating
Cxcl1 and Cxcl2 genes by an alternate stimulus. Analysis of
the Ad-triggered induction of cytokines and chemokines at the
protein level confirmed that the production of CXCL1, CXCL2,
and CCL2 was largely abolished in Il1a/ and Il1a/b/
Immunity
IL-1a Activates Innate Immunity to Adenovirusmice, but was similar in wild-type and Il1b/ mice (Figures 2E
and 2F). The analysis of Ad distribution on spleen sections
by immunofluorescent staining revealed that MZMf in both
Il1a/ and Il1b/ mice are capable of trapping Ad particles
(Figure S5).
IL-1a is synthesized as a precursor protein, pro-IL-1a (Dinar-
ello, 1996). However, upon cell stimulation with ligands for
TLRs, IL-1RI, or TNF-RI, pro-IL-1a is processed in the cytoplasm
by neutral proteases, including calpains (Kobayashi et al., 1990),
leading to the translocation of the N-terminal IL-1a pro-piece (IL-
1a-NTP) to the nucleus, whereas mature IL-1a is released from
the cell (Werman et al., 2004). Staining of spleen sections with
IL-1a-specific Ab revealed that by 1 hr after Ad injection, macro-
phages in marginal zone express IL-1a. However, by 3 hr after
virus injection, IL-1a staining was primarily localized to the nuclei
of these cells, suggesting IL-1a activation through preprotein
processing (Figure 3A). Semiquantitative analysis of the number
Figure 2. IL-1a Is the Dominant Mediator of
an Innate Immune Response to Ad In Vivo
(A) The mRNA expression for IL-1a, IL-1b, CXCL1,
and CXCL2 in spleens of mice 30 min after Ad
injection, analyzed by the RNase protection assay.
Representative gels with mRNA for corresponding
cytokines and chemokines are shown in biological
duplicates. n = 3. C, mock-infected mice, injected
with saline.
(B) Quantitative representation of mRNA expres-
sion from the gel shown in (A) after phosphorim-
ager analysis. Graphs show mean ± SD. n = 6.
n.s., not statistically significant. *p < 0.01. AU, arbi-
trary units.
(C) IL-1a, IL-1b, and CXCL2mRNA in livers of mice
30 min after Ad injection analyzed by the RNase
protection assay. Data are representative of three
independent experiments.
(D) Quantitative representation of mRNA expres-
sion from the gel shown in (C) after phosphorim-
ager analysis. Graphs show mean ± SD. n = 6.
n.s., not statistically significant. *p < 0.01.
(E) Mouse cytokine array panel showing differ-
ences in the proinflammatory cytokines and che-
mokines in spleen of wild-type (WT) and Il1a/,
Il1b/, and Il1a/b/ mice 1 hr after Ad injec-
tion, determined by Proteome Profiler antibody
array. Representative blot from four independent
experiments is shown. Pos-C are dots that
show the manufacturer’s internal positive control
samples on the membrane. Control, the spleen
protein sample of a mouse injected with saline.
(F) The amounts of proinflammatory cytokines and
chemokines in the spleens of mice 1 hr after Ad
injection. The amounts of analytes shown on y
axis were determined for 50 mg of splenic tissue.
Graphs show means ± SD. n = 4. Mock, negative
control mice injected with saline. n.s., not statisti-
cally significant. *p < 0.01.
of MZMf with IL-1a-positive nuclei
revealed that in mice injected with Ad,
IL-1a translocated to the nuclei of more
than 80% of IL-1a-expressing cells (Fig-
ure 3B). Collectively, these finding iden-
tify IL-1a as a primary cytokine mediating the initiation of an
innate immune response to Ad in vivo.
MZMf Activate IL-1a Independently of Inflammasome,
MyD88, TRIF, and TRAF6 Signaling
To evaluate whether the NLRP3 inflammasome mediates the
activation of IL-1a in MZMf in vivo in response to Ad, we admin-
istered Ad into mice deficient in inflammasome components
Caspase-1, ASC, and NLRP-3, as well as other proteins involved
in inflammasome activation (P2X7R) (Kanneganti et al., 2006;
Kuida et al., 1995; Mariathasan et al., 2006). Comparative anal-
ysis of IL-1a mRNA in these mice after Ad injection showed no
statistically significant differences in all analyzed strains
(Figure 4A). Moreover, we found that Cxcl1 and Cxcl2 genes
were also activated in Casp1/ and Nlrp3/ mice to amounts
comparable to those observed in wild-type mice. The analysis
of Ad-induced cytokine production at the protein level showedImmunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc. 113
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1b, CXCL1, CXCL2, and CCL2 between wild-type mice and in-
flammasome component-deficient mice (Figures 4B and 4C).
The immunofluorescent staining of Ad particles on spleen
sections of Nlrp3/, Pycard/, and Casp1/ mice confirmed
that MZMf are capable of trapping blood-borne Ad (Figure S6).
Analysis of the transcriptional activation of IL-1a in Myd88/
and Ticam1/ mice (Kawai et al., 1999; Yamamoto et al.,
2003) 30min after Ad injection also showed no statistically signif-
icant differences, compared to wild-type animals (Figure 4D).
After Ad injection, we observed a significant increase in IL-1a
mRNA in mice deficient in TRAF6 (Naito et al., 1999), compared
to control mice. This analysis also showed a lack of Cxcl1 and
Cxcl2 activation in Myd88/ mice, confirming MyD88’s role as
an adaptor for IL-1RI. Collectively, these data demonstrate that
Figure 3. Ad Induces Expression of IL-1a
and Its Translocation to the Nuclei in
Marginal Zone Macrophages
(A–C) Immunofluorescent and confocal micros-
copy analysis of IL-1a expression on spleen
sections of (A) mock-injected or (B) Ad-injected
mice at 1 hr or (C) 3 hr after injection. The physical
border of the germinal centers are depicted by
punctuate lines.
(D–F) Confocal microscopy analysis of colocaliza-
tion of IL-1a-positive staining with marginal zone
macrophage staining. Arrows indicate CD169-
positive cells in the marginal zone, colocalized
with IL-1a-positive staining. Representative
pictures are shown. n = 5.
(G–I) Confocal microscopy analysis shows the
colocalization of nuclei of splenic marginal zone
cells stained with (G) DAPI (blue), (H) IL-1a (red),
and (I) CD169 macrophage marker. Macrophage
cells with colocalized DAPI and IL-1a staining are
shown by arrows.
(J) Semiquantitative presentation of the per-
centage of IL-1a-expressing marginal zone cells
with IL-1a-positive nuclei in mock-injected mice
and Ad-injected mice. The nuclear IL-1a-positive
staining was analyzed in 200 IL-1a-positive cells
on spleen sections of the Ad-injected group. No
IL-1a-positive nuclei were found on spleen
sections of mock-injected animals. n = 6. *p <
0.01.
the IL-1a-mediated activation of an
innate immune response to Ad does not
depend on virus sensing by NLRP3 in-
flammasome components. Furthermore,
the Il1a gene is activated independently
of MyD88- or TRIF-dependent TLRs or
TRAF6.
The IL-1a-Mediated Response to
Ad Is Triggered by Virus Interaction
with b3 Integrin
The extremely early transcriptional acti-
vation of IL-1a and IL-1b after Ad injection
(Figure 1E) suggests that virus sensing
occurs either at the cell surface or shortly
after virus internalization into the macrophage. Ad entry into
a cell is a stepwise process in which the initial binding of the virus
to the cell is mediated by a fiber protein, followed by a homopen-
tameric penton base protein (pIII) interaction with cellular integ-
rins via arginine-glycine-aspartic acid (RGD) amino acid motifs
(Wickham et al., 1993). RGD motif-interacting integrins, and b1-
integrin in particular, are known to activate alarm cytokines
genes, such as IL-1 and TNF-a (Attur et al., 2000; Yurochko
et al., 1992). To evaluate the contribution of RGD motif-interact-
ing integrins in the induction of anti-Ad innate immune
responses, we administered Ad into mice deficient for either b3
(Itgb3/) or b5 (Itgb5
/) integrins, or mice where b1 integrin
gene was deleted in hematopoietic cells (h-Itgb1/). In addition,
we injected wild-type mice with an Ad mutant, AdDRGD
(Shayakhmetov et al., 2005a), that possesses an RGD motif114 Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc.
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IL-1a Activates Innate Immunity to AdenovirusFigure 4. Activation of an IL-1a-Mediated Innate Response to Ad Does Not Depend on NLRP3 Inflammasome, MyD88, TRIF, or TRAF6
(A) The mRNA expression for IL-1a, IL-1b, CXCL1, and CXCL2 in spleens of mice 30 min after Ad injection, analyzed by the RNase protection assay, and quan-
tified after phosphorimager analysis of the RNA gels. C, mock-infected mice, injected with saline. Graphs show mean ± SD. n = 4. Except for the columns indi-
cated by the star, no statistically significant differences between experimental groups and WT group were identified (p > 0.05). *p < 0.01. AU, arbitrary units.
(B) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and Nlrp3/, Pycard/,
Casp1/, and Il1r1/ mice 1 hr after Ad injection, determined by Proteome Profiler antibody array. Representative blot from three independent experiments
is shown. Pos-C are dots that show the manufacturer’s internal positive control samples on the membrane. Mock, the spleen protein sample of a mouse injected
with saline.
(C) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were
determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 4. Mock, negative control mice injected with saline. n.s., not statistically significant.
(D) IL-1a, CXCL1, and CXCL2 mRNA levels in spleens of mice 30 min after Ad injection, determined by the RNase protection assay and quantified after phos-
phorimager analysis of the RNA gels. Graphs show mean ± SD. n = 4. *p < 0.01. C, mock-infected mice, treated with saline. n.s., not statistically significant.three amino acid deletion within its penton protein and analyzed
the transcriptional activation of Il1a, Il1b, Cxcl1, and Cxcl2. This
analysis revealed that IL-1a mRNA was significantly elevated in
all virus-injected groups, regardless of integrin expression,
compared to mock-injected mice (Figures 5A and 5B), implying
that the transcriptional activation of Il1a does not require virus-in-
tegrin interactions. However, absolute amounts of IL-1a mRNA
were 60% to 70% lower in virus-injected integrin-deficient
mice compared to the amounts of IL-1a mRNA in virus-injected
wild-type or b1 integrin heterozygous (h-Itgb1
+/) mice
(Figure 5B). Similarly, reduced amounts of IL-1a mRNA were
also observed in wild-type mice injected with AdDRGD virus,
compared to those of wild-type mice injected with unmodifiedAd. In contrast to Il1a activation after Ad injection, IL-1b,
CXCL1, and CXCL2 mRNA were significantly reduced in
Itgb3/ mice, but not in other experimental groups (Figure 5B).
Administration of wild-type mice with AdDRGD also resulted in
reduced expression of IL-1b, CXCL1, and CXCL2 mRNA, impli-
cating the importance of direct interaction between viral RGD
motifs and cellular b3 integrins for activation of these cytokines
and chemokines. Consistent with these findings, the analysis
of Il1a, Il1b, andCxcl2mRNAexpression in the liver also revealed
that for all of these genes, their expression was significantly
lower in Itgb3/mice, or wild-type mice injected with AdDRGD,
compared to control animals (Figures 5C and 5D). We further
confirmed at the protein level that the production of all analyzedImmunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc. 115
Immunity
IL-1a Activates Innate Immunity to AdenovirusFigure 5. The Engagement of b3 Integrins by Ad Is Critical for Initiation of the Innate Immune Response
(A) The mRNA expression for IL-1a, IL-1b, CXCL1, and CXCL2 in spleens of wild-type mice (WT) and h-Itgb1/, Itgb3/, Itgb5/ mice, as well as WT mice
injected with Ad mutant lacking RGD amino acid motif (AdDRGD) 30 min after Ad injection, analyzed by the RNase protection assay. Representative gels
with mRNA for corresponding cytokines and chemokines are shown in biological duplicates. n = 3. C, mock-infected mice, injected with saline.
(B) Quantitative representation of mRNA expression from the gel shown in (A) after phosphorimager analysis. Graphs show mean ± SD. Statistically significant
differences between experimental groups and mock-injected controls (indicated by C) or WT injected with Ad are indicated by the star. *p < 0.01. WT mice
injected with AdDRGD are indicated by the arrow. AU, arbitrary units. n = 6.
(C) IL-1a, IL-1b, andCXCL2mRNA in livers ofmice 30min after Ad injection analyzed by theRNase protection assay. Data are representative of three independent
experiments.
(D) Quantitative representation of mRNA expression from the gel shown in (C) after phosphorimager analysis. Graphs showmean ± SD. n = 6. Statistically signif-
icant differences between experimental groups and WT mice injected with Ad are indicated by the star. *p < 0.01.
(E) Mouse cytokine array panel showing differences in the proinflammatory cytokines and chemokines in spleen of wild-type (WT) and h-Itgb1/, Itgb2/,
Itgb3/ mice or WT mice injected with Ad or AdDRGD 1 hr after virus injection, determined by Proteome Profiler antibody array. Representative blot from
four independent experiments is shown. Pos-C are dots that show the manufacturer’s internal positive control samples on the membrane. Control, the spleen
protein sample of a mouse injected with saline.
(F) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad injection. The amounts of analytes shown on y axis were deter-
mined for 50 mg of splenic tissue. Graphs showmeans ± SD. n = 4. Mock, negative control mice injected with saline. Statistically significant differences between
experimental groups and WT mice injected with Ad are indicated by the star. *p < 0.01.116 Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc.
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mice and mice injected with AdDRGD than in control wild-type
mice (Figures 5E and 5F), mice with hematopoietic cells deficient
for b1 integrin, or mice deficient for non-RGD-interacting b2 in-
tegrin (Figure 5E). These data demonstrate a critical role of Ad
RGD motif-mediated interaction with b3 integrin in the full-scale
transcriptional activation of Il1a and Il1b and other analyzed
cytokines and chemokines. It also implies that Ad-b3 integrin
interaction is required for the functional activation of IL-1a,
leading to the expression of IL-1RI-dependent CXCL1 and
CXCL2 chemokines.
Ad Interaction with b3 Integrin Is Required for Nuclear
Translocation of IL-1a-NTP
Immunofluorescent staining of Ad particles in Itgb3/ mice
confirmed that MZMf in these mice can trap Ad after its intrave-
nous injection (Figure S7). However, similar analysis revealed
that when wild-type mice were injected with AdDRGD, there
was a marked reduction in Ad-specific staining associated with
cells in the marginal zone (Figure S7). To quantify the total
amount of Ad genomic DNA associated with spleen tissue after
intravenous virus injection, we used quantitative real-time PCR.
This analysis showed that the highest amounts of Ad genomes
were present in spleens of wild-type mice, compared to other
analyzed groups (Figure S8A). Moreover, we found a statistically
significant 80% reduction in the amount of AdDRGD DNA asso-
ciated with spleen tissue, compared to the amount of Ad DNA in
wild-type animals. To compensate for the reduced amounts of
AdDRGD in the spleen, we injected mice with a 10-fold higher
dose of the virus (1011 virus particles per mouse) and found
that at this high dose, colocalization of AdDRGD particles with
MZMf was restored (Figure S7; AdDRGD, 1011 virus dose). We
next analyzed the innate immune response to a high-dose
AdDRGD at the protein level. This analysis revealed that there
was a 60% reduction in the amounts of IL-1a found in the
spleens of mice injected with a high dose of AdDRGD, compared
to IL-1a amounts in control mice, injected with a standard (1010
virus particles per mouse) dose of Ad. However, we found no
activation of IL-1RI-dependent cytokines and chemokines in
mice after an injection of a high dose of AdDRGD, implying
that IL-1a protein was not activated to induce IL-1RI signaling
(Figures S8B and S8C).
Ad injection into mice showed IL-1a activation and transloca-
tion of N-terminal IL-1a propiece (IL-1a-NTP) into the macro-
phage nuclei (Figure 3). To analyze whether the injection of
wild-type mice with AdDRGD or Itgb3/ mice with unmodified
Ad would induce translocation of IL-1a-NTP into the nuclei of
MZMf, we injected mice with high doses of viruses and stained
spleen sections with an IL-1a-specific antibody, as well as an
antibody for MZMf. Confocal microscopy analysis showed
high amounts of IL-1a-specific staining in MZMf of wild-type
and Itgb3/ mice injected with Ad as well as in wild-type mice
injected with AdDRGD (Figure 6). However, the nuclei of IL-1a-
expressing cells in Ad-injected Itgb3/ mice or Ad5DRGD-
injected wild-type mice were spared of IL-1a staining, demon-
strating the lack of IL-1a processing and translocation of
IL-1a-NTP into the nuclei of infected cells (Figure 6;
Figure S8D). Collectively, these data demonstrate that Ad RGD
motif binding to b3 integrin on MZMf is a critical event that leadsto the IL-1a-mediated activation of the innate immune and
inflammatory macrophage responses to Ad in vivo.
Virus-Mediated Endosome Rupture Is Critical for the
Functional Activation of IL-1a, but Not for the
Expression of Il1a Gene
Ad RGD motif-mediated interaction with cellular integrins trig-
gers the signaling that facilitates virus internalization into the
cell and also initiates a virus disassembly program, promoting
the release of the viral protein pVI, which exhibits endosomolytic
activity (Wiethoff et al., 2005). To better determine whether Ad-
mediated endosome rupture is required for IL-1a activation at
the transcriptional or protein-processing levels, we analyzed
the spleens of the mice that were injected with a mutant virus
ts1. Ts1 is a thermo-sensitive Ad mutant that possesses a single
point mutation in the viral protease p23, and when grown at
a nonpermissive temperature, ts1 is deficient at the endosome
rupture step of infection (Greber et al., 1996). Intravenous injec-
tion of wild-type mice with ts1 resulted in a highly efficient virus
colocalization with splenicMZMf, suggesting that ts1 is not defi-
cient at the internalization step of infection (Figure S9).Moreover,
ts1 injection induced significant elevation in IL-1a gene tran-
scription and protein synthesis, compared to mock-injected
mice, suggesting that virus recognition by macrophage recep-
tors occurs prior to the endosome rupture step of infection
(Figure 7). However, the absolute amounts of IL-1a mRNA and
protein were lower after ts1 injection, compared to those
observed in Ad-injectedmice. Also,we did not observe an activa-
tion of the IL-1RI-dependent chemokines CXCL1, CXCL2, and
CCL2 in response to ts1, suggesting that the produced IL-1a
protein did not mature and failed to activate IL-1R signaling
(Figures 7B and 7C). Collectively, these data showed that IL-1a
gene activation and protein synthesis occurred prior to and inde-
pendentlyof theendosome rupture stepofAd infection.However,
virus-induced endosome rupture greatly amplified IL-1a gene
transcription and triggered functional maturation of IL-1a.
DISCUSSION
In this report we provide evidence for a mechanism of a viral
pathogen-mediated activation of innate immunity that suggests
virus sensing at the cell surface that does not require virus-asso-
ciated nucleic acid recognition by intracellular PRRs. By using
a set of mice deficient for critical mediators of innate immunity
and inflammation, we demonstrated that macrophage-derived
IL-1a is the principal activator of the innate immune response
to a dsDNA virus, Ad, in vivo. Activation of IL-1a does not require
MyD88, TRIF, or TRAF6 signaling and occurs inmice deficient for
IL-1b, IFN-IR, or inflammasome components caspase-1, ASC,
and NLRP3. Collectively, these findings suggest that signaling
pathways that were earlier implicated in the activation of an
innate antiviral response and leading to type I IFN production
(Takeuchi and Akira, 2009) are not involved in triggering inflam-
matory and innate immune responses to Ad. The IL-1a-mediated
response critically depends on viral RGDmotif-mediated binding
tomacrophage b3 integrins, which occurs prior to the internaliza-
tion of the virus into the cell (Greber et al., 1993; Wickham et al.,
1993) and is further amplified by the virus-mediated endosome
rupture. These findings define a unique innate immune pathwayImmunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc. 117
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IL-1a Activates Innate Immunity to AdenovirusFigure 6. Confocal Microscopy Analysis of IL-1a Translocation into the Nuclei ofMZMf inWT and Itgb3/Mice Injectedwith Ad, orWTMice
Injected with AdDRGD Mutant
Mice were injected intravenously with a high dose of the indicated viruses (1011 virus particles per mouse), and 3 hr later spleens were harvested and sections
were prepared and stained with DAPI (blue) to detect nuclei of splenocytes, as well as Abs specific for CD169 (green) or IL-1a (red). Confocal images were ob-
tainedwith a Zeiss 510Meta Confocalmicroscope. The physical border of splenic germinal centers are indicated by punctuate lines.Marginal zonemacrophages
expressing IL-1a are indicated by arrows. Representative pictures are shown. n = 4.and implicate b3 integrin as a sensor of pathogen-associated
molecular patterns and IL-1a as a mediator of innate antiviral
response.
By using various in vitro systems, several groups reported
earlier that type I IFN is a key mediator of innate immune and
inflammatory responses to Ad (Nociari et al., 2007; Zhu et al.,
2007a). However, our in vivo studies do not support this conclu-
sion because we did not observe the activation of type I IFN
transcription shortly after Ad injection, and the abrogation of
secondary cytokine and chemokine gene transcription occurs
only in Il1r1/ mice and not in Ifnar/ mice. The discrepancy
between our in vivo data and in vitro data obtained by these
groups could be explained by the differential pathways of Ad
entry into cells in vitro and in vivo. By using Tlr9/ mice, we
also excluded the involvement of this sensor in activation of
innate immunity to Ad in vivo, because the expression of all
analyzed early cytokines and chemokines were comparable in
wild-type and TLR9-deficient mice.118 Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc.Recently, Muruve et al. (2008) proposed that the NLRP3 in-
flammasome may recognize cytosolic dsDNA, including the Ad
genome, and trigger the activation of host innate immune
responses. In contrast to this model, our data suggest that
NLRP3, ASC, and caspase-1 are not involved in the sensing of
Ad entry into macrophages in vivo. First, the transcriptional acti-
vation of the primary cytokines IL-1a and IL-1b in response to Ad
occurs up to similar amounts in Nlrp3/, Pycard/, Casp1/,
and Il1r1/ mice. Second, the secretion of secondary chemo-
kines CXCL1 and CXCL2 was substantially higher in Nlrp3/
and Casp1/ mice than in the Il1r1/ mice. Finally, the major
reduction of the anti-Ad response in mice deficient for IL-1a
and the high anti-Ad response in Il1b/ mice clearly show the
nonessential role of IL-1b, NLRP3, and other inflammasome
components in triggering innate immune and inflammatory
responses to Ad in vivo. The discrepancy between the conclu-
sions drawn from Muruve et al. (2008) and our present study
can be explained by the differences in virus delivery routes, the
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IL-1a Activates Innate Immunity to AdenovirusFigure 7. Transcriptional and Functional
Activation of IL-1a in Response to ts1
Mutant Virus
(A) Mice were injected with Ad or ts1 mutant and
IL-1amRNA expression was analyzed 30 min later
by RNase protection assay. Graphs show mean ±
SD. n = 4. Statistically significant differences
between experimental groups are indicated by
the star. *p < 0.01. C, mock-infected mice, treated
with saline. AU, arbitrary units.
(B) Mouse cytokine array panel showing differ-
ences in the proinflammatory cytokines and che-
mokines in spleen of wild-type (WT) mice injected
with Ad or ts1 at indicated doses (virus particles
per mouse) 1 hr after virus injection, determined
by Proteome Profiler antibody array. Representa-
tive blot from three independent experiments is
shown. Pos-C are dots that show the manufacturer’s internal positive control samples on the membrane. Control, the spleen protein sample of a mouse injected
with saline.
(C) The amounts of proinflammatory cytokines and chemokines in the spleens of mice 1 hr after Ad or ts1 injection. The amounts of analytes shown on y axis were
determined for 50 mg of splenic tissue. Graphs show means ± SD. n = 3. Mock, negative control mice injected with saline. Statistically significant differences
between WT mice injected with Ad or ts1 are indicated by the star. *p < 0.01.experimental readouts, and the times of analyses, all of which
differed between our study and those described by Muruve
et al. (2008).
Although earlier studies showed that IL-1a is produced by
epithelial cells infected with respiratory syncytial virus or human
Ad serotype 37 (Ad37) (Chang et al., 2002, 2003), IL-1a-IL-RI
pathway was recently defined as a key pathway of inflammatory
host response to necrotic cells (Chen et al., 2007). One of the
functions of intracellular IL-1a is to lower the threshold of
NF-kB- and AP-1-dependent gene expression to subpicomolar
concentrations of inflammatory stimuli (Werman et al., 2004).
Our finding that IL-1a is activated and translocated into the
macrophage nuclei in response to Ad in vivo may indicate the
host attempt to establish a higher state of alert facilitating
the activation of a downstream cascade of inflammatory media-
tors. Although the Ad receptor(s) on macrophages activating
IL-1a transcription is as yet unknown, the short time required
for IL-1a gene induction implies that the virus sensing event
occurs either at the cell surface or shortly after the internalization
of virus particle into the cell. This is consistent with our observa-
tion that the ts1 mutant virus, which cannot rupture the endo-
somes, is still capable of activating the transcription and
synthesis of IL-1a.
Ad internalization into a cell is mediated by cellular integrins
(Wickham et al., 1993). Several classes of integrins, such as
a5b1, avb3, and avb5, bind proteins containing RGD amino acid
motif. We demonstrate that the lack of b3 integrin, but not b1 or
b5 integrins, ablates IL-1a-mediated activation of an innate
immune response to Ad.We also found that although Ad induces
IL-1a transcription and synthesis in Itgb3/ mice, IL-1a is not
translocated to the nuclei of infected cells, suggesting the lack
of IL-1a activation. Importantly, the same phenotype of macro-
phage responses was observed in wild-type mice, injected
with an Ad mutant lacking an RGD amino acid motif within the
virus capsid (Zubieta et al., 2005) and ts1 virus mutant, which
cannot rupture cellular endosomes. These data suggest a two-
step model for the activation of the innate response to Ad,
when the initial pro-IL-1a expression in MZMf occurs indepen-dently of virus-integrin interaction after virus binding to a plasma
membrane receptor or internalization into the cell. However,
virus-b3 integrin interaction is critical for the amplification of IL-
1a transcription and is ultimately required for the functional acti-
vation of IL-1a protein, likely via facilitating the virus-mediated
endosome rupture. Earlier studies of Ad-induced inflammatory
responses in vitro and in vivo showed that the induction of proin-
flammatory mediators such as TNF-a, RANTES, IP-10, MIP-1a,
and MIP-1b was significantly reduced if cells or animals were
infected with an Ad mutant lacking the RGD amino acid motif
(Koizumi et al., 2006; Schoggins and Falck-Pedersen, 2006;
Tibbles et al., 2002). Our findings may provide a mechanistic
link between Ad-integrin interactions and the activation of IL-1a
that triggers innate immune and inflammatory responses.
Viruses are obligate intracellular parasites that cannot repro-
duce outside their host cell. To ensure their evolutionary survival,
viruses developed elaborate evasion mechanisms that prevent
recognition of the virus infection within the cell and downregulate
activation of antiviral responses. However, the detection of path-
ogens at the cell surfacemay bemore beneficial and effective for
the host than their intracellular detection because the finely
tuned very first steps of infection, such as virus attachment
and internalization into the cell, are unlikely targets for evasion
because of the severe evolutionary pressure. In fact, the minor
variations in amino acid composition of the hemagglutinin,
a receptor binding protein of the avian influenza H5N1 virus,
may modulate the virulence of H5N1 viruses and restrict the
cross-species infection transmission (Yen et al., 2009). Epidemi-
ological studies in humans have revealed that the lack of the
chemokine receptor and HIV coreceptor, CCR5, on the sur-
face of human leukocytes leads to an abortive virus infection and
resistance to HIV (Mosier, 2000). In this study we demonstrate
a pathway of activation of innate immunity that is triggered by
the virus binding to a macrophage plasma membrane receptor
and IL-1a as a principal mediator of this response. Further char-
acterization of this pathway may provide valuable insights into
the mechanisms of pathogen recognition and the activation of
host responses to invading pathogens.Immunity 31, 110–121, July 17, 2009 ª2009 Elsevier Inc. 119
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Viruses
The replication-defective Ad5-based vectors, Ad5 (Ad5L), Ad5/35L, Admutant
lacking the RGD motifs in the penton protein, AdDRGD, and ts1 Ad mutant,
were previously constructed and described in detail elsewhere.
Experimental Animals
All studies were conducted in accordancewith the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and the Institutional Animal
Care and Use Committee guidelines of the University of Washington, Seattle,
WA. C57BL/6 mice were purchased from Charles River, Wilmington, MA.
Il1r1/ and P2rx7/, Itgb1flox/flox, Itgb3/, and Itgb5/ mice were
purchased from Jackson Laboratory. Casp1/ mice were described in Kuida
et al. (1995); Pycard/ and Nlrp3/ mice were provided by V. Dixit (Genen-
tech) (Mariathasan et al., 2004). Tlr9/, Ticam/, and Myd88/ mice were
provided by S. Akira (Osaka University). Traf6/ mice were provided by J.-I.
Inoue (University of Tokyo). Ifnar/ mice were described in Kolumam et al.
(2005). Il1a/, Il1a/b/ mice were described in Horai et al. (1998). Il1b/
mice were described in Shornick et al. (1996). In these mice, Il1b gene
possesses a neo gene insertion within exon 4, disrupting IL-1b protein produc-
tion. However, mutated IL-1b mRNA is detectable by IL-1b exon 1-specific
RNA probe, supplied by BD Biosciences for RNase protection assay. All
mice were on C57BL/6 genetic background, matched by age and housed in
specific-pathogen-free facilities.
Adenovirus Delivery In Vivo
Unless otherwise specified, mice were injected with 1010 virus particles in
200 ml of phosphate-buffered saline (PBS) via tail vein infusion. At indicated
times, mice were sacrificed and organs were harvested for further analyses.
Proteome Profiler Antibody Arrays
A ‘‘Proteome Profiler antibody array: Mouse Cytokine Array Panel A’’
(#ARY006, R&D System) was used, according to the manufacturer’s instruc-
tions. Each spleen was homogenized in 2 ml of sample solution, and 1 ml
(1/2 spleen) was used to incubate with each membrane on a rocking platform
overnight. Membranes were developed with ImmunoStar HRP-sustrate (Bio-
Rad, #1705041).
Antibodies and Other Materials
Propidium iodide was purchased from Sigma (Cat. #81845). Antibodies were
from Abcam: biotinylated anti-Ad-Hexon (#ab34374, final dilution 1/100),
anti-Ad5 (#ab6982, final dilution 1/50), anti-IL-1a (#ab9724, final dilution 5
mg/ml). Other antibodies were from BMA: anti-Marco (BMA, #T2026, 2 mg/
ml), anti-Moma-1 (or CD-169) (BMA, #T2011, 2 mg/ml); or from BD: anti-IgM
(#553405, 1 mg/ml), FITC-labeled anti-GR-1 (#553127). Secondary antibodies
and reagents were from Jackson Immunoresearch: Cy2- or Cy3-labeled strep-
tavidin, or donkey anti-rat or rabbit antibodies, Cy2-, Cy3-, or HRP-labeled.
Statistical Analyses
Statistical analysis in each independent experiment was performed with an
unpaired, two-tailed Student’s t test. Data are reported as mean ± standard
deviation. p < 0.05 was considered statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
figures, and three movies and can be found with this article online at http://
www.cell.com/immunity/supplemental/S1074-7613(09)00270-2.
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